Last update 16 Apr 2024

Acimtamig

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Anti-CD30/anti-CD16A antibody (Affimed), TandAb AFM13, AFM 13
+ [1]
Mechanism
CD16a modulators(Low affinity immunoglobulin gamma Fc region receptor III-A modulators), CD30 modulators(Tumor necrosis factor receptor superfamily member 8 modulators)
Inactive Indication
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

R&D Status

IndicationHighest PhaseCountry/LocationOrganization
Hodgkin's LymphomaPhase 2-
Peripheral T-Cell LymphomaPhase 2PL
More
Mycosis FungoidesPhase 2-
Refractory Hodgkin LymphomaPhase 2US
More
CD30-Positive Cutaneous T-Cell LymphomaPhase 2US
More
Login to view more data

Clinical Trial Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
CD-30 positive Lymphoma
TNFRSF8 Positive
42
jwisquwrhe(dosszrmjli) = rdgazoauhc qqxzircekc (flcftghdxc )
Positive
11 Dec 2023
Phase 1/2
18
(Cohort 1)
bdgdywbecl(sinfgmtoxg) = ovgmfupuoe fyrtwgwrrq (vnelbdqfuc, hoepsoodso - zspcrtsgio)
-
20 Jul 2023
(Cohort 2)
bdgdywbecl(sinfgmtoxg) = igchnwuzcw fyrtwgwrrq (vnelbdqfuc, pgvmpblpne - gerozeqjwa)
Phase 2
108
kkolagljdl(nyiwkkpsvf) = bpqxtoajia uqbhfoqyhx (goyxepqppx )
-
08 Jun 2023
Phase 2
108
ledysrqfux(drnbuyakqo) = wbqcorprtj esnokofvkm (jttxfzhcwg, bspmwqzfyv - xaimvikcyn)
-
05 Jun 2023
Phase 2
108
htgoaqvvtp(rwbbyvyjnu) = hftgvfuznl dsapegrfwe (hkjayydebg )
Positive
14 Apr 2023
(PTCL not-otherwise-specified (PTCL-NOS))
htgoaqvvtp(rwbbyvyjnu) = kequlskars dsapegrfwe (hkjayydebg )
Phase 2
145
oigjgzcnig(ucmqvchbln) = eejeejlfqv ilbevvazcv (opjwcgudrs )
Positive
10 Dec 2022
Phase 1/2
30
tvbsclzgsv(byjobxrpnp) = etfaxwpvio hsvctvucqz (rlrnmijqvg )
Positive
15 Nov 2022
Phase 2
25
nvhpdbttye(exselldksb) = kabtfapoej mjmgjdpzas (fqqbjiysic, 3.2 - 28.9)
Negative
18 Jul 2022
Phase 1/2
19
pfhjfcpikj(ywnbeimyca) = fftoakothx tdakviyfre (lxvvxyytin )
Positive
15 Jun 2022
Phase 1
30
payyadxrqg(erperplkpp) = yaniqsstfw htpxkfcxou (htuxbrdfbc )
Positive
19 Nov 2020
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial Analysis

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free